Atacicept, CAS 845264-92-8

Product Description: Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Gross JA, et, al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001 Aug;15(2):289-302. /[2]Gross JA, et, al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000 Apr 27;404(6781):995-9.

CAS Number: 845264-92-8

Molecular Weight: N/A

Compound Purity: 99.50

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99446-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99446-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK